Skip to main content
. 2022 Dec 15;17(1):1641–1656. doi: 10.1515/biol-2022-0102

Figure 3.

Figure 3

The role of EPCs n cancer. CD45+ EPCs inhibit (1) T-cell proliferation, (2) T-cell activation, (3) IFN-γ and TNF-α production, and (4) CD8+ T-cell cytotoxicity. CD45 EPCs promote (5) tumor cell metastasis and invasion and (6) tumor growth and cell proliferation.